GlassScriptPhysician profile
Pedro Ambriz
NPI 1568008290
$5,476.28
in general payments reported to CMS, 2019-2025
18 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,528 · 2022: $2,384 · 2023: $404 · 2024: $59.52 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,167.56 | 2021-2022 | |
| Abbvie INC. | $1,144.72 | 2021-2023 | |
| Janssen Biotech, INC. | $508.20 | 2021-2024 | Tremfya, Simponi Aria |
| Ucb, INC. | $472.22 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $359.20 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $340.62 | 2021-2022 | |
| Glaxosmithkline, LLC. | $310.94 | 2021-2022 | |
| Lilly USA, LLC | $299.98 | 2021-2022 | |
| Pfizer INC. | $209.43 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $185.73 | 2021-2022 | |
| Horizon Therapeutics Plc | $139.63 | 2021 | |
| Esperion Therapeutics, INC. | $101.81 | 2025 | Nexletol |
| Octapharma USA, INC. | $81.03 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $39.23 | 2021 | |
| Aurinia Pharma U.S., INC. | $35.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $33.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.47 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Ambriz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.